In Zhao and colleagues’ meta-analysis, they demonstrated that in patients with high-grade glioma tumor, the OPN gene and protein expression was significantly higher than that in patients with low-grade glioma [50]. This evidence concerns the gene SPP1 and central nervous system cancer.